The builder contracted to carry out expansion works at Casey Hospital in Berwick has sued its insurer for refusing to cover $4 million in damages caused by a subcontractor’s delays.
A class action over alleged botched cosmetic surgeries can drop claims against one surgeon, but the doctor will remain a party so other defendants can point the finger at him.
US lab products giant Beckman Coulter has successfully opposed an Australian biotech’s bid to trade mark ‘Cytophex’ for its stem cell expansion system, with an IP Australia delegate finding the mark is too similar to Beckman’s ‘CytoFLEX’ mark.
The ACT government’s has appointed Multiplex to support design and planning work for the next stage of the territory’s northside hospital project in Canberra.
A group member in a class action against Johnson & Johnson unit DePuy has filed an appeal after he lost a challenge to his compensation determination, 12 years after the case settled.
A group of class actions against healthcare providers in Victoria that allegedly failed to pay junior doctors for overtime have settled for $175 million.
Victorian healthcare providers facing class actions on behalf of junior doctors have turned to one law firm to lead their defence. And that firm might be about to get a lot busier.
The plaintiff in an unsuccessful class action against Bayer over its Essure contraceptive device wants to see whether she can avoid paying costs in the case before deciding on whether to appeal the loss.
Pharmaceutical giant Lundbeck has resolved its battle with Novartis unit Sandoz over top-selling drug Lexapro, a battle that has raged for years and across multiple courts.
Australian cancer care company GenesisCare has been sued by Novartis unit Endocyte for allegedly infringing the patents for its prostate cancer treatment Pluvicto. The lawsuit, filed in the Federal Court in January, accuses GenesisCare of infringing or threatening to infringe patents held by Endocyte and Purdue Research Foundation by supplying lutetium, the generic version of…